- Filed
- Jan 31, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Jan 27, 2025 | 9.38M sh |
| Short Term Investments | Q2 2025 · Dec 31, 2024 | $7.16M |
| Short Term Investments | Q2 2025 · Jun 30, 2024 | $12.1M |
| Cash And Equivalents | Q2 2025 · Dec 31, 2024 | $2.54M |
| Cash And Equivalents | Q2 2025 · Jun 30, 2024 | $2.84M |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $1.68M |
| Current Liabilities | Q2 2025 · Jun 30, 2024 | $1.3M |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $6.44M |
| Total Liabilities | Q2 2025 · Jun 30, 2024 | $6.05M |
| Current Assets | Q2 2025 · Dec 31, 2024 | $16.72M |
| Current Assets | Q2 2025 · Jun 30, 2024 | $21.92M |
| Total Assets | Q2 2025 · Dec 31, 2024 | $37.44M |
| Total Assets | Q2 2025 · Jun 30, 2024 | $37.2M |
| Shares Diluted | Q2 2025 · Dec 31, 2023 | 9.24M sh |
| Shares Diluted | Q2 2025 · Dec 31, 2023 | 9.24M sh |
| Capex | Q2 2025 · Dec 31, 2023 | $401.59K |
| Operating Cash Flow | Q2 2025 · Dec 31, 2023 | −$345.19K |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | $31.4M |
| Stockholders Equity | Q2 2025 · Sep 30, 2023 | $31.6M |
| Stockholders Equity | Q2 2025 · Jun 30, 2023 | $31.81M |
| Eps Diluted | Q2 2025 · Dec 31, 2023 | −$0.03 |
| Eps Diluted | Q2 2025 · Dec 31, 2023 | −$0.06 |
| Eps Basic | Q2 2025 · Dec 31, 2023 | −$0.03 |
| Eps Basic | Q2 2025 · Dec 31, 2023 | −$0.06 |
| Sga Expense | Q2 2025 · Dec 31, 2023 | $1.58M |
| Sga Expense | Q2 2025 · Dec 31, 2023 | $3.12M |
| Net Income | Q2 2025 · Dec 31, 2023 | −$269.15K |
| Net Income | Q2 2025 · Dec 31, 2023 | −$526.76K |
| Operating Income | Q2 2025 · Dec 31, 2023 | −$476.08K |
| Operating Income | Q2 2025 · Dec 31, 2023 | −$944.67K |
| Gross Profit | Q2 2025 · Dec 31, 2023 | $1.11M |
| Gross Profit | Q2 2025 · Dec 31, 2023 | $2.18M |
| Cost Of Revenue | Q2 2025 · Dec 31, 2023 | $2.25M |
| Cost Of Revenue | Q2 2025 · Dec 31, 2023 | $4.56M |